UZH-Logo

Maintenance Infos

Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)


Zhou, T; Georgeon, S; Moser, R; Moore, D J; Caflisch, A; Hantschel, O (2014). Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348). Leukemia, 28(2):404-407.

Citations

9 citations in Web of Science®
22 citations in Scopus®
Google Scholar™

Altmetrics

Downloads

0 downloads since deposited on 01 Jul 2014
0 downloads since 12 months

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Department of Biochemistry
07 Faculty of Science > Department of Biochemistry
Dewey Decimal Classification:570 Life sciences; biology
Language:English
Date:2014
Deposited On:01 Jul 2014 15:43
Last Modified:05 Apr 2016 17:56
Publisher:Nature Publishing Group
ISSN:0887-6924
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:https://doi.org/10.1038/leu.2013.205
PubMed ID:23823659
Permanent URL: https://doi.org/10.5167/uzh-96989

Download

[img]
Filetype: PDF - Registered users only
Size: 838kB
View at publisher

Author Collaborations